II. Epidemiology
- Prevalence: 2-3 per 1000 persons (U.S.)
- Age (mean): 45 years old
- Gender
- Women represent 62% of cases (esp. middle aged women)
III. Types
IV. Causes
- Triggers
- Younger patients
- Typically no underlying structural heart disease
- Older patients (age over 50 years)
- Coronary Artery Disease
- Congestive Heart Failure
- Cardiomyopathy
- Valvular heart disease
- Uncommon Cardiac Causes
- Congenital Heart Disease
- Infiltrative Cardiomyopathy (e.g. Sarcoidosis, Tuberculosis)
- Electrical Disorders (e.g. Prolonged QT Syndrome, WPW)
- Prior Atrial Surgery
V. Symptoms: Episodic
- See Supraventricular Tachycardia
- Anxiety
- Episodes that have resolved before presentation are often misdiagnosed as Panic Attack
- Chest pressure
- Dyspnea
- Fatigue
- Light headed
- Palpitations
VI. Labs
- See Supraventricular Tachycardia
- Precautions
- Paroxysmal Supraventricular Tachycardia does not require routine labs in many cases (esp. known prior history of PSVT)
- Patients who are asymptomatic after PSVT resolves, and without underlying other risks need not undergo laboratory testing
VII. Diagnosis
- See Supraventricular Tachycardia
- Differentiate Sinus Tachycardia from other SVT
VIII. Management: Acute
- See Supraventricular Tachycardia Management in the Adult
- See Supraventricular Tachycardia Management in the Child
- ABC Management
- Mnemonic: IV-O2-Monitor
- Obtain IV Access
- Oxygen Delivery
- Cardiopulmonary monitor
- Hemodynamically Unstable Patients
- Do not delay Synchronized Cardioversion
- Stable patients
- Vagal Maneuvers
- First line measure in stable patients, and remarkably effective
- Adenosine 6 mg IV, then 12 mg IV
- Avoid if preexcitation (e.g. WPW) present
- Consider Synchronized Cardioversion
- Vagal Maneuvers
- Refractory PSVT with a narrow complex
- Metoprolol 5 mg IV over 1 to 2 minutes every 5 minutes as needed (up to 15 mg)
- Diltiazem 0.25 mg/kg IV over 2 minutes and may repeat after 15 min, at 0.35 mg/kg IV
- Refractory PSVT with a wide complex
- Procainamide
- Load 10 to 17 mg/kg IV at 20 to 50 mg/min
- Maintenance 1 to 4 mg/min IV
- Amiodarone IV
- Load 150 mg IV over 10 min (may repeat up to 1 dose)
- Next 1 mg/min for 6 hours
- Next 0.5 mg/min for 18 hours
- Max Total Loading Dose: 10 grams
- Procainamide
IX. Management: Chronic
- Cardiology Referral
- See Supraventricular Tachycardia for indications
- Medical Management: Rate control agents
- Contraindications
- Preexcitation such as WPW Syndrome (refer for ablation)
- Heart Failure with Reduced Ejection Fraction (HFrEF)
- Medications
- Diltiazem 240 to 360 mg orally daily
- Metoprolol 50 to 400 mg/day
- Metoprolol Succinate (Toprol XL) once daily
- Metoprolol Tartrate (Lopressor) divided twice daily
- Contraindications
- Medical Management: Antiarrhythmics
- Consult electrophysiology; higher risk agents
- Flecainide
- Propafenone
-
Cardiac Ablation Indications
- AVNRT Indications
- Recurrent AVNRT
- AVRT Indications
- First-line in all cases
- Focal Atrial Tachycardia Indications
- Recurrent Focal Atrial Tachycardia
- Secondary Cardiomyopathy due to Atrial Tachycardia
- AVNRT Indications